Referenser

  1. Folkhälsomyndigheten. Kunskap om tobaks- och nikotinprodukters skadeverkningar – Återredovisning av regeringsuppdrag. In; 2023. p. 37.

  2. Valen H, Becher R, Vist GE, Holme JA, Mdala I, Elvsaas I, et al. A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. Int J Cancer 2023;153(12):1942-53.

  3. Heir T, Eide G. Injury proneness in infantry conscripts undergoing a physical training programme: smokeless tobacco use, higher age, and low levels of physical fitness are risk factors. Scand J Med Sci Sports 1997;7(5):304-11.

  4. Byhamre ML, Araghi M, Alfredsson L, Bellocco R, Engström G, Eriksson M, et al. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies. Int J Epidemiol 2021;49(6):2041-50.

  5. Caviness CM, Anderson BJ, Stein MD. Impact of Nicotine and Other Stimulants on Sleep in Young Adults. J Addict Med 2019;13(3):209-14.

  6. Gunnerbeck A, Lundholm C, Rhedin S, Mitha A, Chen R, D'Onofrio BM, et al. Association of maternal snuff use and smoking with Sudden Infant Death Syndrome: a national register study. Pediatr Res 2023;94(2):811-9.

  7. Byhamre ML. Snus use and mortality: associations, potential mechanisms, and socioeconomic aspects. Umeå: Umeå University; 2022.

  8. Kohut SJ. Interactions between nicotine and drugs of abuse: a review of preclinical findings. Am J Drug Alcohol Abuse 2017;43(2):155-70.

  9. Larsson M. Nikotin, alkohol och opioider – samverkar vid beroendeutveckling. Läkartidningen 2021.

  10. Mobarrez F, Antoniewicz L, Hedman L, Bosson JA, Lundbäck M. Electronic cigarettes containing nicotine increase endothelial and platelet derived extracellular vesicles in healthy volunteers. Atherosclerosis 2020;301:93-100.

  11. Lyytinen G, Brynedal A, Anesäter E, Antoniewicz L, Blomberg A, Wallén H, et al. Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial. Cardiovasc Toxicol 2023;23(7-8):255-64.

  12. Socialstyrelsen. Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor - Stöd för styrning och ledning. In; 2018. p. 79.

  13. Peres J. Water Pipe Smoking: Not Risk Free. JNCI: Journal of the National Cancer Institute 2014;106(8).

  14. Enghag M, Höjer J. Vattenpip­rökning kan ge allvarlig kolmonoxid­förgiftning - Risk för bestående neurologiska skador. Läkartidningen 2011(26).

  15. Fromme H, Dietrich S, Heitmann D, Dressel H, Diemer J, Schulz T, et al. Indoor air contamination during a waterpipe (narghile) smoking session. Food Chem Toxicol 2009;47(7):1636-41.

  16. Flor LS, Anderson JA, Ahmad N, Aravkin A, Carr S, Dai X, et al. Health effects associated with exposure to secondhand smoke: a Burden of Proof study. Nat Med 2024;30(1):149-67.

  17. Tarhun YM. The effect of passive smoking on the etiology of serous otitis media in children. Am J Otolaryngol 2020;41(3):102398.

  18. Cook DG, Strachan DP. Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997;52(12):1081-94.

  19. Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax 1997;52(11):1003-9.

  20. Malmberg N. Tobaksindustrins miljöpåverkan en genomgång av forskningsläget 2020. Stockholm: VISIR; 2020. Available from: https://tobaksfakta.se/wp-content/uploads/2021/02/Rapport_Sammanfattning-tobakens-miljo%CC%88pa%CC%8Averkan_2020-12-01.pdf

  21. Novotny TE, Hamzai L. Cellulose acetate cigarette filter is hazardous to human health. Tob Control 2023.

  22. Bize R, Burnand B, Mueller Y, Rège-Walther M, Camain JY, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2012;12:Cd004705.

  23. Westerdahl E, Engman KO, Arne M, Larsson M. Spirometry to increase smoking cessation rate: A systematic review. Tob Induc Dis 2019;17:31.

  24. Martín-Luján F, Santigosa-Ayala A, Pallejà-Millán M, Rey-Reñones C, Villalobos F, Solà R. Effectiveness of the spirometry-based motivational intervention to quit smoking: RESET randomised trial. Eur J Gen Pract 2023;29(1):2276764.

  25. Matuszewski PE, Comadoll SM, Costales T, Zerhusen T, Coale M, OʼToole RV. Novel Application of Exhaled Carbon Monoxide Monitors: Smoking Cessation in Orthopaedic Trauma Patients. J Orthop Trauma 2019;33(11):e433-e8.

  26. Guterstam J, Sandell M. Nya svenska diagnoskoder för beroendetillstånd i remission. Läkartidningen 2024;121(202).

  27. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008;53(9):1217-22.

  28. Sims TH, Fiore MC. Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? CNS Drugs 2002;16(10):653-62.

  29. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:Cd000146.

  30. Stead LF, Koilpillai P, Lancaster T. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2015(10):Cd009670.

  31. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, et al. Breastfeeding and the use of human milk. Pediatrics 2005;115(2):496-506.

  32. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012(4):Cd006103.

  33. Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K. Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis. Harm Reduct J 2009;6:25.

  34. Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. Jama 2021;326(1):56-64.

  35. Walker N, Smith B, Barnes J, Verbiest M, Parag V, Pokhrel S, et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction 2021;116(10):2847-58.

  36. Rose JE, Behm FM. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm. Nicotine Tob Res 2017;19(8):999-1002.

  37. Fagerström K, Gilljam H, Metcalfe M, Tonstad S, Messig M. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. Bmj 2010;341:c6549.

  38. Rigotti NA, Benowitz NL, Prochaska J, Leischow S, Nides M, Blumenstein B, et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. Jama 2023;330(2):152-60.

  39. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016;387(10037):2507-20.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida